Literature DB >> 17445091

Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia.

X Zheng1, W Li, Y Song, Y Hu, G L Ferrell, N L Esmon, C T Esmon.   

Abstract

BACKGROUND: Activated protein C (APC) protects the host from severe sepsis. Endothelial protein C receptor (EPCR) is expressed on both hematopoietic leukocytes and non-hematopoietic endothelium, and plays a key role in protein C activation.
OBJECTIVES: We explore the influence of EPCR deletion on the responses to lipopolysaccharide (LPS) and then determine whether the observed differences are due to loss of hematopoietic or non-hematopoietic EPCR. METHODS AND
RESULTS: After LPS challenge, EPCR null (Procr(-/-)) mice exhibited more thrombin and cytokine generation, neutrophil sequestration in the lung and a higher mortality rate than Procr(+/-) mice. Procr(+/-) BM/Procr(-/-) (non-hematopoietic Procr(-/-)) and Procr(-/-) BM/Procr(+/-) (hematopoietic Procr(-/-)) chimeric mice were generated by bone marrow (BM) transplantation. Compared with control Procr(+/-) mice, non-hematopoietic Procr(-/-) mice exhibited reduced protein C activation by thrombin and exaggerated responses to LPS challenge, whereas Procr(+/-) mice and hematopoietic Procr(-/-) mice exhibited similar protein C activation by thrombin and similar responses to LPS challenge.
CONCLUSIONS: EPCR deletion exaggerates the host responses to LPS primarily due to deficiency of EPCR on the non-hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445091     DOI: 10.1111/j.1538-7836.2007.02592.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  22 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Monitoring of endothelial dysfunction in critically ill patients: the role of endothelial progenitor cells.

Authors:  Sushma K Cribbs; Greg S Martin; Mauricio Rojas
Journal:  Curr Opin Crit Care       Date:  2008-06       Impact factor: 3.687

3.  The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.

Authors:  Giulia Pavani; Lacramioara Ivanciu; Armida Faella; Oscar A Marcos-Contreras; Paris Margaritis
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

Review 4.  Endothelial cell protein C receptor: a multiliganded and multifunctional receptor.

Authors:  L Vijaya Mohan Rao; Charles T Esmon; Usha R Pendurthi
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

Review 5.  The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.

Authors:  Eimear M Gleeson; James S O'Donnell; Roger J S Preston
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

6.  Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Authors:  Qiulan Ding; Likui Yang; Seyed Mahdi Hassanian; A R Rezaie
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

7.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

8.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

9.  Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Authors:  Eimear M Gleeson; James S O'Donnell; Emily Hams; Fionnuala Ní Áinle; Bridget-Ann Kenny; Padraic G Fallon; Roger J S Preston
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

10.  PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.

Authors:  A P Reiner; C L Carty; N S Jenny; C Nievergelt; M Cushman; D J Stearns-Kurosawa; S Kurosawa; L H Kuller; L A Lange
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.